Christiana Care Health Systems
Newark, Delaware, 19713, United States
NCT Number: NCT03976037
Combined misoprostol and Foley bulb catheter has been shown to be an effective induction method. However, optimal route of administration for misoprostol has not been established.
Therefore, the purpose of this study is to compare the effectiveness and safety of combination buccal miso-foley to combination vaginal miso-foley for third trimester cervical ripening and induction of labor.
Looking for future studies?
Notify Me18 year–55 year
Female
Interventional
Early Phase 1
Newark, Delaware, 19713, United States
This randomized controlled trial of consenting women undergoing induction of labor with combined misoprostol and Foley catheter seeks to efficacy of vaginal versus buccal misoprostol route of administration.
This project will include 216 women presenting at Christiana Care Health System. Women will be included if they are at least 37 weeks gestation, have a singleton pregnancy, have intact membranes and are undergoing an induction of labor using a Foley catheter combined with misoprostol. Following admission, women will be randomized into either vaginal or buccal misoprostol.
Women will be randomized with equal probability to the intervention group using block randomization stratified by party.
Patients will receive 25 micrograms of misoprostol along with the insertion of a16F Foley catheter. Misoprostol can be repeated up to five additional times for a maximum of 24 hours or a total of 6 doses if the patient is not contracting more than 3 times per 10 minutes. The remainder of labor management will be at the discretion of each woman's obstetric provider.
Prior to discharge from the hospital, baseline demographic and clinical data will be obtained via chart review
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
As described in previous research (Levine LD, Downes KL, Elovitz MA, Parry S, Sammel MD, Srinivas SK. Mechanical and Pharmacologic Methods of Labor Induction: A Randomized Controlled Trial. Obstet Gynecol. 2016;128(6):1357-1364)
Women randomized to either vaginal or buccal misoprostol-cervical Foley group will have both misoprostol and a cervical Foley placed. Patients will receive 25 micrograms of vaginal or buccal misoprostol along with the insertion of a16F Foley catheter with stylet. The Foley balloon catheter will be filled with 30cc balloon inserted digitally or by direct visualization with a speculum. The Foley bulb will be placed just above the level of the internal os and inflated with 30cc of sterile water.
vaginal or Buccal misoprostol can be repeated up to five additional times for a maximum of 24 hours or a total of 6 doses if the patient is not contracting more than 3 times per 10 minutes. If the patient is contracting more than 3 times per 10 minutes after 6 hours, oxytocin protocol is initiated.
Other names: cytotec
Time frame: through study completion, an average of 2 year
as time from initiation of induction method to delivery time, regardless of mode of delivery.
Time frame: through study completion, an average of 2 year
yes/no
Time frame: through study completion, an average of 2 year
s time from initiation of induction method to dilatation ≥6cm
Time frame: through study completion, an average of 2 year
defined as length of time from admission for induction to discharge postpartum, days
Time frame: through study completion, an average of 2 year
The reason for induction: NRFHT, arrest of dilation, arrest of descent, failed IOL, other
Time frame: through study completion, an average of 2 year
yes/no
Time frame: through study completion, an average of 2 year
yes/no
Time frame: through study completion, an average of 2 year
yes/no; fundal tenderness and fever that required treatment with antibiotics
Time frame: From time of delivery to time of hospital discharge; up to 6 weeks
the need for additional wound closure or the need for antibiotics
Time frame: through study completion, an average of 2 year
yes/no
Time frame: through study completion, an average of 2 year
yes/no
Time frame: through study completion, an average of 2 year
yes/no
Time frame: through study completion, an average of 2 year
yes/no
Time frame: through study completion, an average of 2 year
the presence of maternal fever ≥100·4°f in the presence of maternal or fetal tachycardia or fundal tenderness
Time frame: through study completion, an average of 2 year
yes/no
Time frame: through study completion, an average of 2 year
yes/no
Time frame: through study completion, an average of 2 year
yes/no
Time frame: through study completion, an average of 2 year
yes/no
Time frame: From time of delivery to hospital discharge; up to 6 weeks
defined as intubation and mechanical ventilation for a minimum of 12 hours
Time frame: From time of delivery to hospital discharge; up to 6 weeks
yes/no
Time frame: From time of delivery to hospital discharge; up to 6 weeks
yes/no
Time frame: From time of delivery to hospital discharge; up to 6 weeks
yes/no
Time frame: From time of delivery to hospital discharge; up to 6 weeks
yes/no
Time frame: From time of delivery to hospital discharge; up to 6 weeks
yes/no
Time frame: From time of delivery to hospital discharge; up to 6 weeks
yes/no
Time frame: From time of delivery to hospital discharge; up to 6 weeks
yes/no
Christiana Care Health Services
Other
Buccal Versus Vaginal Misoprostol In Combination With Foley Bulb for Labor Induction at Term: a Randomized Controlled Trial
Acronym: BEGIN
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04955847
Cesarean Section, Induction of Labor
Amiens, France
View Trial DetailsNCT07503184
Dexamethasone, Female Urogenital Diseases and Pregnancy Complications
Multan, Punjab Province, Pakistan
View Trial DetailsNCT07261332
Female Urogenital Diseases and Pregnancy Complications, Fetal Membranes, Premature Rupture
Lahore, Punjab Province, Pakistan
View Trial DetailsNCT02477085
Induction of Labor
Paris, France
View Trial Details